Literature DB >> 12818367

Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin.

Richard A Isbrucker1, Jennifer Cummins, Shirley A Pomponi, Ross E Longley, Amy E Wright.   

Abstract

Dictyostatin-1 had previously been isolated from a marine sponge of the genus Spongia sp. and described as a cytotoxic agent to murine and human cancer cells, but its mechanism of activity was unknown. In a routine screening assay used to detect cytotoxic compounds of marine origin, dictyostatin-1 was identified as a highly active component in an extract from a Lithistida sponge and exploration into its pharmacology was pursued. Initial studies demonstrated that dictyostatin-1 arrested cells in the G(2)/M phase of the cell cycle. Staining of these cells with antitubulin revealed cells having multiple aster formations and microtubule matrix bundling patterns similar to that seen in cells exposed to paclitaxel. Dictyostatin-1 was able to induce the polymerization of purified bovine brain tubulin in vitro and the polymerized tubulin remained stable at cold temperatures. Dictyostatin-1 also proved to be highly potent in two paclitaxel-resistant human cancer cell lines expressing active P-glycoprotein. Together, these results indicate that dictyostatin-1 is a potent inducer of tubulin polymerization and retains activity in cells expressing the P-glycoprotein efflux pump.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818367     DOI: 10.1016/s0006-2952(03)00192-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  32 in total

Review 1.  The Lithistida: important sources of compounds useful in biomedical research.

Authors:  Amy E Wright
Journal:  Curr Opin Biotechnol       Date:  2010-12       Impact factor: 9.740

2.  Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.

Authors:  Rundi Ma; Gang Song; Wenbing You; Lijian Yu; Weiming Su; Mingneng Liao; Yongping Zhang; Laizhen Huang; Xiaoyu Zhang; Tingxi Yu
Journal:  Cancer Chemother Pharmacol       Date:  2007-11-21       Impact factor: 3.333

3.  Metallacycle-Mediated Cross-Coupling in Natural Product Synthesis.

Authors:  Natasha F O'Rourke; Matthew J Kier; Glenn C Micalizio
Journal:  Tetrahedron       Date:  2016-09-07       Impact factor: 2.457

Review 4.  Conformation-activity relationships of polyketide natural products.

Authors:  Erik M Larsen; Matthew R Wilson; Richard E Taylor
Journal:  Nat Prod Rep       Date:  2015-08       Impact factor: 13.423

5.  MT-Stabilizer, Dictyostatin, Exhibits Prolonged Brain Retention and Activity: Potential Therapeutic Implications.

Authors:  Kurt R Brunden; Nicola M Gardner; Michael J James; Yuemang Yao; John Q Trojanowski; Virginia M-Y Lee; Ian Paterson; Carlo Ballatore; Amos B Smith
Journal:  ACS Med Chem Lett       Date:  2013-07-23       Impact factor: 4.345

6.  Selective synthesis of (2Z,4E)-dienyl esters by ene-diene cross metathesis.

Authors:  Gustavo Moura-Letts; Dennis P Curran
Journal:  Org Lett       Date:  2007-01-04       Impact factor: 6.005

Review 7.  Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Authors:  Carlo Ballatore; Kurt R Brunden; Donna M Huryn; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith
Journal:  J Med Chem       Date:  2012-09-28       Impact factor: 7.446

Review 8.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

9.  Early effects of lasonolide a on pancreatic cancer cells.

Authors:  Richard A Isbrucker; Esther A Guzmán; Tara P Pitts; Amy E Wright
Journal:  J Pharmacol Exp Ther       Date:  2009-08-19       Impact factor: 4.030

Review 10.  Impact of marine drugs on animal reproductive processes.

Authors:  Francesco Silvestre; Elisabetta Tosti
Journal:  Mar Drugs       Date:  2009-11-06       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.